Doctors have struggled for years to preserve fertility in young cancer patients, with few choices available for patients.
Instead, she chose IVM. Before she began her cancer treatment, doctors removed immature eggs from her ovaries, and froze them in liquid nitrogen. Then, the eggs were later developed in a laboratory.
Five years after the IVM procedure, the woman, who was not named, had recovered from cancer but found herself infertile and unable to conceive for a year, the news release said.
Using hormones to stimulate her ovaries might have prompted them to produce more eggs — but it may have also caused the cancer to recur. So instead, doctors thawed her infertile eggs and inseminated them with a sperm injection, before transferring the early-stage embryo into her uterus.
The woman then became pregnant, and delivered a healthy baby boy named Jules last July, said the news release — a world first.
“We were delighted that the patient became pregnant without any difficulty and successfully delivered a healthy baby at term,” said Grynberg in the release. “This success represents a breakthrough in the field of fertility preservation.”
Until now, no cancer patients had successfully gotten pregnant and given birth using eggs that were frozen and matured this way. The closest thing has been patients whose eggs are removed, immediately fertilized, and transferred back into the patient without freezing.
Typically, when women use in vitro fertilization to conceive children, immature eggs are discarded because there has been little scientific evidence that they can be frozen, thawed, and matured in a lab, Aimee Eyvazzadeh, a San Francisco-based reproductive endocrinologist, said in 2018.
Previous studies and researchers have tried, but with little success. In one 2018 study, scientists in the United States and Britain removed eggs and matured them in the lab — but the eggs appeared to have many abnormalities.
To perform this successfully would be a “game changer,” Eyvazzadeh said in 2018.
Now, it’s happened. Though this technique isn’t the most common or efficient option, it provides a much-needed second option for cancer patients who face complications — and is a remarkable step forward in fertilization research.